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ABSTRACT 
Diabetic peripheral neuropathy (DPN) is associated with progressive loss of sensation. 
restriction of lower limb joint range of motion， and gait alternation. These impairments are 
significant risk for diabetic plantar ulcer. The aim of the present study is to evaluate the 
relationship between neuropathy and plantar pressure profile in diabetic patients with different 
d巴greesof peripheral neuropathy. Twenty-four patients of typ巴2diabet巴swith DPN were 
enrolled and clasifi巴dinto 3 groups according to DPN severity， and simultaneously estimated 
sensory and motor nerve conduction velocity (SCV， MCV)， toe and ankle joint range of 
motion， and peak plantar pressure. Plantar ar巴awas divided into 4 regions: toe， for巴foot，midfoot 
and rearfoot. To prevent the巴xtremevariation， patients with plantar callus were excluded 
SCV， MCV， toe and ankle joint range of motion， and peak plantar pressur巴 oftoe and forefoot 
were corr巴latedwith DPN sev巴rity.Moreover， the peak pressure ratio of toe to forefoot was 
significantly increased in proportIon to DPN severi匂Tand th巴 restrictionof toe joint range of 
motion. These results indicate that except patients with plantar callus， increasing degrees of 
DPN restricts the toe joint flexibility and the relative peak plantar pressure of toe rises in 
accordance with DPN severity. 
(Accept巴don December 14， 2011) 




































































































I期 E期 E以上 全体
例数 (M/F) 6 7 11 24 
年齢(歳) 60.7:!:14.9 65.4:!: 8.8 60.l:!: 7.9 61.8:!: 10.1 
権病期間(年) 15.0:!:5.7 13.6:!:9.6 18.2:!: 8.3 16.0:!: 8.l 
BMI kg/m2 25.8:!:5.6 23.2:!:4.0 20.6:!:2.4 22.7:!:4.3 
HbA1c (%; JDS) 7.5:!: 1.8 7.5 :!:0.4 8.2:!:2.3 7.5:!: 1.9 
糖尿病性網膜症(あり/全体) 116 2/7 9/11 12/24 
糖尿病性腎症(あり/全体) 316 3/7 7/11 13/24 





















Neuropack 8 (Nihon Kohd巴n，Japan)を用いて，
左下肢の腔骨神経伝導速度 (MCV)および排腹
神経伝導速度 (SCV)を測定した























期間16.0:! 8.l年だった平均BMIは22.7:! 4.3， 





者を分類したところ，病期 1(ω6仔例1ω)， I (7例)， 











病期 I E E以上
SCV (m/s) 44.1 :!:4.4 44.1:!: 4.4 33.3:!:6.2 
MCV (m/s) 41.4:!: 4.1 45.0 :!:6.5 36.0:!:4.2 
第一中足駈節関節可動域(度) 65.7:!:7.3 59.9:!: 18.0 32.7土9.7
足関節可動域(度) 14.7:!:7.6 1O.6:!:4.7 4.5:!:2.2 
足E止部最大圧 (g/cm') 2121 :!:905 2233:!:516 3032:!: 1163 
前足部最大庄 (g/cm') 4608:!: 1316 4111 :!:96 3422:!:599 
中足部最大圧 (g/cm') 875:!:301 829:!:451 320:!:290 
E重部最大圧 (g/cm') 2981:!: 1202 2489:!:875 2576:!:434 
足祉部/前足部比 0.51 :!:0.28 0.5:!: 0.12 0.88:!:0.30 





SCV (m/s) I r=ー 0.50※











































































































































































































































1) Dyck PJ， Katz KM， Karnes JL， Litchy WJ， 
Klein R， Pach JM. Wilson DM， O'Brien PC， 
Melton LJ， Service FJ. The prevalenc巴 by
staged severity of various types of diabetic 
neuropathy， retinopathy and nephropathy 
in a population-based cohort: the Rochester 
Diabetic Neuropathy Study. Neurology 1993; 
43・817-824
2) Tajima N， Matsushima M， Matsuoka K，
Kawamori R. Iwamoto Y， Akanuma Y， 
A Large-scale， Hospital-based Survey 
on Diabetic Neuropathy in the Tokyo 
14 藤岡洋平
Metropolitan Area. Journal of Japan 
Diabetes Society 2003; 46・301-310
3) Brownlee M， Cersmi A et al. Advanced 
glycosylation end products in tissue and 
biochemical basis of diabetic complication. N 
Engl J Med 1988; 318: 1351-1321. 
4) Mcpoil TG， Yamada W et al. The 
distribution of plantar pressure in American 
Indians with diabetes mellitus. J Am 
Podiatr Med Assoc 2001; 91: 280-287. 
5) Frykberg RG， Lavery LA， Pham H， Harvey 
C， Harkless L， Veves A. Rol巴 ofneuropathy 
and high foot pressures in diabetic foot 
ulceration. Diabetes Care 1998; 21: 1714-
1719. 
6) Stess RM， Jensen SR， Mirmiran R. The role 
of dynamic plantar pressur巴indiabetic foot 
ulcers. Diabetes Care 1997; 20: 855-858. 
7) Veves A， Murray HJ， Young MJ， Boulton 
A]. The risk of foot ulceration in diabetic 
patl巴ntswith high foot pressure: a 
prospective study. Diabetologia 1992; 35・
660-663 







梢神経 2003;14: 225 
11)糖尿病性神経障害を考える会簡易診断基準
をもとにした糖尿病性多発神経障害の病期




に与える影響.プラクテイス 2005; 2: 569-
574 
13) Boulton AJM. Treatment for diabetic 
neuropathy. Curr Diab Rep 2001; 1: 127-132. 
14) Tesfaye S， Chaturvedi N， Eaton SE， Ward 
JD， Man巴sC， Ionescu-Tirgoviste C， Witte 
DR， Fuller JH: EURODIAB Prospectiv巴
Complications Study Group. Vascular risk 
factors and diabetic neuropathy. N Engl J 
Med 2005; 352: 341-350. 
15) Malik RA， Williamson S， Abbott C， 
Carrington AL， Iqbal ]. Schady羽T，Boulton 
A]. Effect of angiotensin-converting enzyme 
(ACE) inhibitor trandolapril on human 
diabetic neuropathy: randomased double-
blind controlled trial. Lancet 1998・352:1978-
1981. 
16) Devaka JS， Fernando DJ et al. Relationship 
of limited joint mobility to abnormal foot 
pressures and diabetic foot ulceration. 
Diabetes Care 1991; 14: 8-11 
17) Boulton AJM， Betts RP， Franks CI， Newrick 
PG， Ward JD， Duckworth T. Abnormalities 
of foot pressure in early diabetic 
neuropathy. Diabet Med 1987; 4: 225目228.
18) Boulton AJM， Hardisty CA， et al. Dynamic 
foot pressure and other studies as 
diagnostic and management aids in diabetic 
neuropathy. Diabetes Car巴 1983;6: 26-33. 
19)河辺信秀，上甲哲士・他.糖尿病性足部潰蕩
の危険因子に対する装具療法の効果理学療
法学 2004; 31: 296-303. 
